145 related articles for article (PubMed ID: 24883149)
21. Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis.
Bantis C; Heering PJ; Aker S; Klein-Vehne N; Grabensee B; Ivens K
Kidney Int; 2004 Jul; 66(1):288-94. PubMed ID: 15200436
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme genotype is not a significant genetic risk factor for idiopathic nephrotic syndrome in Croatian children.
Batinić D; Sertić J; Ćorić M; Konjevoda P; Batinić D; Milošević D
Nephron; 2015; 130(1):29-34. PubMed ID: 25997642
[TBL] [Abstract][Full Text] [Related]
23. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
[TBL] [Abstract][Full Text] [Related]
24. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
[TBL] [Abstract][Full Text] [Related]
25. Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis.
Hori C; Hiraoka M; Yoshikawa N; Tsuzuki K; Yoshida Y; Yoshioka K; Fujisawa K; Tsukahara H; Ohshima Y; Mayumi M
Nephron; 2001 Aug; 88(4):313-9. PubMed ID: 11474225
[TBL] [Abstract][Full Text] [Related]
26. Influence of angiotensin-I-converting-enzyme insertion/deletion gene polymorphism on perioperative hemodynamics after coronary bypass graft surgery.
Popov AF; Hinz J; Liakopoulos OJ; Schmitto JD; Seipelt R; Quintel M; Schoendube FA
J Cardiovasc Surg (Torino); 2008 Apr; 49(2):255-60. PubMed ID: 18431347
[TBL] [Abstract][Full Text] [Related]
27. Effect of angiotensin converting enzyme gene I/D polymorphism in South Indian children with nephrotic syndrome.
Kumar Ramanathan AS; Karuppiah B; Vijayan M; Raju K; Mani D; Chinniah R; Thirunavukkarasu M; Malini Ravi P; Illiayaraja Krishnan J; Senguttuvan P
J Biomed Res; 2019 Jun; 33(3):201-207. PubMed ID: 30333281
[TBL] [Abstract][Full Text] [Related]
28. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
[TBL] [Abstract][Full Text] [Related]
29. Effects of genetic polymorphisms of the renin-angiotensin system in children with nephrotic syndrome.
Tabel Y; Berdeli A; Mir S; Serdaroğlu E; Yilmaz E
J Renin Angiotensin Aldosterone Syst; 2005 Dec; 6(3):138-44. PubMed ID: 16525944
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus.
Yoshida H; Kuriyama S; Atsumi Y; Tomonari H; Mitarai T; Hamaguchi A; Kubo H; Kawaguchi Y; Kon V; Matsuoka K; Ichikawa I; Sakai O
Kidney Int; 1996 Aug; 50(2):657-64. PubMed ID: 8840299
[TBL] [Abstract][Full Text] [Related]
31. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
Diabetes Care; 2003 May; 26(5):1501-6. PubMed ID: 12716812
[TBL] [Abstract][Full Text] [Related]
32. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.
Hernández D; Lacalzada J; Rufino M; Torres A; Martín N; Barragán A; Barrios Y; Macía M; de Bonis E; Lorenzo V; Rodríguez A; González-Posada JM; Salido E
Kidney Int; 1997 Apr; 51(4):1205-11. PubMed ID: 9083287
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.
Usta M; Ersoy A; Dilek K; Ozdemir B; Yavuz M; Güllülü M; Yurtkuran M
J Intern Med; 2003 Mar; 253(3):329-34. PubMed ID: 12603500
[TBL] [Abstract][Full Text] [Related]
34. [I/D relationship between polymorphism of ACE gene and progression of chronic glomerulonephritis].
Kaliev RR; Budaĭchiev AB; Aldashev AA; Mirrakhimov MM
Ter Arkh; 2005; 77(6):12-5. PubMed ID: 16078593
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease.
Shanmuganathan R; Kumaresan R; Giri P
J Postgrad Med; 2015; 61(4):230-4. PubMed ID: 26440392
[TBL] [Abstract][Full Text] [Related]
36. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism.
Hernández D; Lacalzada J; Salido E; Linares J; Barragán A; Lorenzo V; Higueras L; Martín B; Rodríguez A; Laynez I; González-Posada JM; Torres A
Kidney Int; 2000 Aug; 58(2):889-97. PubMed ID: 10916115
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.
Pontremoli R; Ravera M; Viazzi F; Nicolella C; Berruti V; Leoncini G; Giacopelli F; Bezante GP; Sacchi G; Ravazzolo R; Deferrari G
Kidney Int; 2000 Feb; 57(2):561-9. PubMed ID: 10652033
[TBL] [Abstract][Full Text] [Related]
38. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease.
Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD
Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178
[TBL] [Abstract][Full Text] [Related]
39. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
Ha SK; Yong Lee S; Su Park H; Ho Shin J; Jung Kim S; Hun Kim D; Rae Kim K; Yung Lee H; Suk Han D
Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
[TBL] [Abstract][Full Text] [Related]
40. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
Yoshida H; Mitarai T; Kawamura T; Kitajima T; Miyazaki Y; Nagasawa R; Kawaguchi Y; Kubo H; Ichikawa I; Sakai O
J Clin Invest; 1995 Nov; 96(5):2162-9. PubMed ID: 7593601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
